Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• MicroRNA 100%
• Cisplatin 100%
• Autophagy 100%
• Tumor Progression 100%
• Mouse Model 50%
• Chemosensitivity 50%
• ATG5 50%
• ATG12 50%
• Gelatinase B 50%
• MMP9 50%
• Gelatinase A 50%
• MMP2 50%

Medicine and Dentistry

• Bladder Cancer 100%
• Tumor Progression 100%
• Autophagy 100%
• Chemotherapy 100%
• Cancer Therapy 28%
• Cancer Cell 28%
• microRNA 28%
• Muscle Invasive Bladder Cancer 28%
• Cisplatin 28%
• In Vitro 14%
• Recurrent Disease 14%
• Malignant Neoplasm 14%
• Adjuvant Therapy 14%
• Gelatinase B 14%
• Gelatinase A 14%
• Substitution Therapy 14%
• Urinary Tract Cancer 14%
• Tumor Xenograft 14%
• Chemosensitivity 14%
• Beclin 1 14%
• The Cancer Genome Atlas 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Bladder Cancer 100%
• Tumor Growth 100%
• Malignant Neoplasm 42%
• microRNA 28%
• Cisplatin 28%
• Muscle Invasive Bladder Cancer 28%
• Recurrent Disease 14%
• Mouse Model 14%
• Gelatinase B 14%
• Gelatinase A 14%
• Replacement Therapy 14%
• Urinary Tract Cancer 14%
• Beclin 1 14%
• Neoplasm 14%